57 related articles for article (PubMed ID: 1794214)
1. Initial renal growth in diabetic and sodium-loaded spontaneously hypertensive rats (SHR).
Sato T; Nara Y; Kato Y; Yamori Y
Clin Invest Med; 1991 Dec; 14(6):636-41. PubMed ID: 1794214
[TBL] [Abstract][Full Text] [Related]
2. Morphometrical and biochemical differences of endocrine pancreata between spontaneously hypertensive and normotensive rats with or without neonatal streptozotocin-induced diabetes.
Iwase M; Nunoi K; Kikuchi M; Maki Y; Kodama T; Sadoshima S; Fujishima M
Lab Invest; 1989 Jan; 60(1):102-5. PubMed ID: 2521365
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
[TBL] [Abstract][Full Text] [Related]
4. Additive increase in kidney insulin-like growth factor I and initial renal enlargement in uninephrectomized-diabetic rats.
Flyvbjerg A; Frystyk J; Marshall SM
Horm Metab Res; 1990 Oct; 22(10):516-20. PubMed ID: 2079313
[TBL] [Abstract][Full Text] [Related]
5. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-translational regulation of renal insulin-like growth factor binding protein-1 in insulin-deficient diabetes.
Kaufman CR; Catanese VM
J Investig Med; 1995 Apr; 43(2):178-86. PubMed ID: 7537614
[TBL] [Abstract][Full Text] [Related]
7. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
Iwase M
Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
[TBL] [Abstract][Full Text] [Related]
8. Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus.
Amazonas RB; Lopes de Faria JB
Life Sci; 2006 Oct; 79(22):2135-43. PubMed ID: 16890245
[TBL] [Abstract][Full Text] [Related]
9. Increased kidney and liver insulin-like growth factor II/mannose-6-phosphate receptor concentration in experimental diabetes in rats.
Flyvbjerg A; Kessler U; Kiess W
Growth Regul; 1994 Dec; 4(4):188-93. PubMed ID: 7756975
[TBL] [Abstract][Full Text] [Related]
10. Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension.
Yousif MH; Akhtar S; Walther T; Benter IF
Cell Biochem Funct; 2008; 26(2):256-63. PubMed ID: 18035860
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
12. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
Matsumoto K; Morishita R; Tomita N; Moriguchi A; Komai N; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Heart Vessels; 2003 Mar; 18(1):18-25. PubMed ID: 12644877
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic treatment with spirapril on biochemical parameters in streptozotocin-diabetic and spontaneously hypertensive rats.
Parulekar AA; Hakim ZS; Santani DD; Goyal RK
Indian J Exp Biol; 1997 Nov; 35(11):1182-6. PubMed ID: 9567746
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypertension on the development of diabetic cardiomyopathy.
Mathis DR; Liu SS; Rodrigues BB; McNeill JH
Can J Physiol Pharmacol; 2000 Oct; 78(10):791-8. PubMed ID: 11077979
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
16. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension.
Silva KC; Pinto CC; Biswas SK; de Faria JB; de Faria JM
Curr Eye Res; 2007 Jun; 32(6):533-41. PubMed ID: 17612969
[TBL] [Abstract][Full Text] [Related]
17. Alloxan diabetes in spontaneously hypertensive rats: gravimetric, metabolic and histopathological alterations.
Iams SG; Wexler BC
Br J Exp Pathol; 1977 Apr; 58(2):177-99. PubMed ID: 861167
[TBL] [Abstract][Full Text] [Related]
18. Vascular albumin permeability and hypertrophy in a rat model combining streptozotocin-induced diabetes and genetic hypertension.
Hulthén UL; Rumble J; Cooper ME; Johnston CI
J Hypertens; 1995 May; 13(5):529-33. PubMed ID: 7561010
[TBL] [Abstract][Full Text] [Related]
19. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Flyvbjerg A; Thorlacius-Ussing O; Naeraa R; Ingerslev J; Orskov H
Diabetologia; 1988 May; 31(5):310-4. PubMed ID: 2456236
[TBL] [Abstract][Full Text] [Related]
20. Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.
Grønbaek H; Nielsen B; Frystyk J; Flyvbjerg A; Orskov H
Exp Nephrol; 1996; 4(5):295-303. PubMed ID: 8931985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
